Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas

Background: as the most common malignancy of the central nervous system, low-grade glioma (LGG) patients suffered a poor prognosis. Tumor microenvironment, especially immune components, plays an important role in the progression of tumors. Thus, it is critical to explore the key immune-related genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ming, Jia, Jiaoying, Cui, Yan, Peng, Yong, Jiang, Yugang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615402/
https://www.ncbi.nlm.nih.gov/pubmed/34827528
http://dx.doi.org/10.3390/brainsci11111529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615402/
https://www.ncbi.nlm.nih.gov/pubmed/34827528
http://dx.doi.org/10.3390/brainsci11111529

Ejemplares similares